Ni, Y; Barzman, D; Bachtel, A; Griffey, M; Osborn, A; Sorter, M. Finding warning markers: Leveraging natural language processing and machine learning technologies to detect risk of school violence.. International Journal of Medical Informatics. 2020; 139.

Razak, KA; Dominick, KC; Erickson, CA. Developmental studies in fragile X syndrome.. Journal of Neurodevelopmental Disorders. 2020; 12(1).

Wink, LK; Reisinger, DL; Horn, P; Shaffer, RC; O'Brien, K; Schmitt, L; Dominick, KR; Pedapati, EV; Erickson, CA. Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study.. Journal of Autism and Developmental Disorders. 2021; 51(4):1392-1399.

Miyakoshi, M; Schmitt, LM; Erickson, CA; Sweeney, JA; Pedapati, EV. Can We Push the "Quasi-Perfect Artifact Rejection" Even Closer to Perfection?. Frontiers in Neuroinformatics. 2021; 14.

Schaefer, TL; Ashworth, AA; Tiwari, D; Tomasek, MP; Parkins, EV; White, AR; Snider, A; Davenport, MH; Grainger, LM; Becker, RA; Robinson, CK; Mukherjee, R; Williams, MT; Gibson, JR; Huber, KM; Gross, C; Erickson, CA. GABAA Alpha 2,3 Modulation Improves Select Phenotypes in a Mouse Model of Fragile X Syndrome.. Frontiers in Psychiatry. 2021; 12.